BioCentury

BioCentury This Week

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.

Husk at besøge podcastens hjemmeside og støtte skaberen: www.biocentury.com

Forfatter

BioCentury

Kategori

Science

Podcastens hjemmeside

www.biocentury.com

Seneste episode

20. okt. 2026

Hvor kan du lytte?

Podcasts i appen Replaio Radio Kommer snart

Podcasts kommer snart til appen. Installer nu, og vær den første til at se en helt ny tilgang til podcasts

Hent den på Google Play Installer gratis Android næsten 10 mio. downloads · 4,8 i bedømmelse iOS snart

Episoder

Ep 76 Pt. 3 - Delivering the Evidence for Accelerated Approval 01.09.2021

Reach us by sending a text

Ep 76 Pt. 2 - Standards of Evidence for Accelerated Approval 30.08.2021

Reach us by sending a text

Ep 76 Pt. 1 - Accelerated Approval's Big Picture 30.08.2021

Reach us by sending a text

Ep. 75 - Back to School Preview, plus Pfizer Eats Trillium 24.08.2021

Reach us by sending a text

Ep. 74 - Vertex's Road Map & Innovation in MS 16.08.2021

Reach us by sending a text

Ep. 73 - Next Up in COVID with Otello Stampacchia and Umer Raffat 13.08.2021

Reach us by sending a text

Ep. 72 - Modality Matters: M&A Heats Up, Galbraith Maps AZ's BD 09.08.2021

Reach us by sending a text

Ep. 71 - Lessons from China’s Market Turmoil, Plus Distillery on Tap 03.08.2021

Reach us by sending a text

Ep. 70 - Prepping for China’s IP law with Jones Day’s Tony Chen 29.07.2021

Reach us by sending a text

Ep. 69 - Allaying Aduhelm Concerns, Plus Master Protocols, Arvinas-Pfizer 27.07.2021

Reach us by sending a text

Ep. 68 - Drug Pricing Pressure, Plus European Deal Trends 20.07.2021

Reach us by sending a text

Ep. 67 - Aduhelm: a Tangled Plot; Plus, INTREPID Pandemic Planning 13.07.2021

Reach us by sending a text

Ep. 66 - Biotechs hit 3Q with Coolers Full of Cash; plus Distillery on Tap 06.07.2021

Reach us by sending a text

Ep. 65 - Optimism for Intellia's CRISPR Breakthrough, Concerns about Aduhelm 29.06.2021

Reach us by sending a text

Ep. 64 - Amyloid Analysis: Stress Testing FDA's Logic on Surrogate Endpoint 24.06.2021

Reach us by sending a text

Ep. 63 - Woodcock, Noubar and Genmab’s dealmaking: A BioCentury Podcast 21.06.2021

Reach us by sending a text

Ep. 62 - Reflecting on the Implications of Aduhelm's Approval: A BioCentury Podcast 14.06.2021

Reach us by sending a text

Ep. 61 - Dissecting FDA's Aducanumab Decision 08.06.2021

Reach us by sending a text

Ep. 60 - D-Day for Aducanumab: What's at stake 02.06.2021

Reach us by sending a text

Ep. 59 - KRAS to the Future; plus ARPA-H & EGFR 02.06.2021

Reach us by sending a text

Ep. 58 - LAG3 Before You Leap; plus BEE21, G20 Highlights 24.05.2021

Reach us by sending a text

Ep. 57 - Financing Scandinavia; plus IP Waivers, Long Covid & AAV Pays 10.05.2021

Reach us by sending a text

Ep. 56 - FDA’s ODAC Bind; plus NK Cell Engagers and Company Creation in Europe 04.05.2021

Reach us by sending a text

Ep. 55 - German Plays Deliver on Data, plus Accelerated Approval on Trial 27.04.2021

Reach us by sending a text

Ep. 54 - Patient Groups’ Pandemic Pain; plus Voters’ Rights and Synthetic Lethality 20.04.2021

Reach us by sending a text

Lyt til podcasten BioCentury This Week i Replaio

Radio og podcasts i én app - gratis og uden tilmelding. Installer i dag, og gå ikke glip af lanceringen

Hent den på Google Play

Replaio er ikke podcastudgiver; programmernes navne, coverbilleder og lyd tilhører deres ophavsmænd og distribueres via offentlige RSS-feeds.